Friday 29 March 2019

Focus on immunotherapy and patient perspective at IASLC 2019 Small Cell Lung Cancer Meeting

(International Association for the Study of Lung Cancer) While non-small cell lung cancer (NSCLC) is the more common form of lung cancer and attracts the lion's share of the research funding, recent developments in small cell lung cancer may be shifting that slightly. In order to capitalize on these recent developments, researchers who focus on small cell lung cancer (SCLC) will gather in New York City at Memorial Sloan Kettering Cancer April 3-5, 2019, for the IASLC 2019 Small Cell Lung Cancer Meeting.

from EurekAlert! - Social and Behavioral Science https://ift.tt/2V4uPVF

No comments:

Post a Comment